Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Masimo Corporation - Common Stock
(NQ:
MASI
)
166.09
+0.52 (+0.31%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Masimo Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
18
19
Next >
Cisco To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday
April 15, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
How's AT&T Handling Things?
April 09, 2024
We've also got a look at 3M's spinoff, gold prices, and the beef industry.
Via
The Motley Fool
Can a New CEO Fix Boeing?
April 06, 2024
We also talk with e.l.f. Beauty CEO Tarang Amin about how the company is succeeding.
Via
The Motley Fool
Boeing's Leadership Shake-Up
April 06, 2024
And IWG CEO Mark Dixon talks with us about the global shift toward hybrid work.
Via
The Motley Fool
Analyst Scoreboard: 5 Ratings For Masimo
March 25, 2024
Via
Benzinga
Masimo Corp. (NASDAQ: MASI) Making Surprising Moves in Monday Session
March 25, 2024
Via
Investor Brand Network
Recap: Masimo Q4 Earnings
February 27, 2024
Via
Benzinga
Earnings Scheduled For February 27, 2024
February 27, 2024
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.
Via
Benzinga
Tim Cook-Led Tech Giant Appeals To US Court For Overturning Import Ban On Its Apple Watches
April 06, 2024
Apple is appealing to reverse a U.S. import ban on certain Apple Watches stemming from a patent dispute with Masimo Corporation, arguing the patented Masimo wearable was theoretical and challenging the...
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Masimo Responds to Politan Capital’s Nomination of Director Candidates and Refutes Politan’s False Claims
April 01, 2024
From
Masimo
Via
Business Wire
Masimo Breaks Out To Eight-Month High On Proposed Consumer Biz Separation
March 25, 2024
The company is considering a separation for its audio and consumer-facing businesses.
Via
Investor's Business Daily
Disney To Rally Around 17%? Here Are 10 Top Analyst Forecasts For Monday
March 25, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
A Preview Of Masimo's Earnings
February 26, 2024
Via
Benzinga
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session
March 25, 2024
Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news.
Via
Benzinga
Patient Monitoring Device Maker Masimo Contemplates Separation of Consumer Business As Activist Investor Seeks Expanded Board Presence
March 25, 2024
Politan Capital Management's Quentin Koffey prepares for a proxy battle, seeking additional Masimo Corporation board seats. With a 9% stake, Koffey aims to influence the $7.1 billion market value...
Via
Benzinga
Wall Street Set To Open Weak Lower As Tech Feels China Chill: Analyst Says Stay Bullish 'If And Until This Changes'
March 25, 2024
Major U.S. index futures edged lower on Monday, reflecting the cautious mood from last week’s close.
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
March 25, 2024
We are starting off the day with a breakdown of the biggest pre-market stock movers that traders need to know about on Monday morning.
Via
InvestorPlace
Politan Nominates Two Independent Candidates for Masimo Board
March 25, 2024
From
Politan Capital Management
Via
Business Wire
Esperion Therapeutics, Masimo And Other Big Stocks Moving Higher In Monday's Pre-Market Session
March 25, 2024
U.S. stock futures were lower this morning, with the Dow futures falling by around 50 points on Monday. Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) rose sharply in today’s pre-market trading.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Dada Nexus, Salarius Pharmaceuticals And 3 Stocks To Watch Heading Into Monday
March 25, 2024
With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
March 22, 2024
Via
Benzinga
Masimo Corporation Board of Directors Authorizes Management to Evaluate the Separation of Consumer Business
March 22, 2024
From
Masimo Corporation
Via
Business Wire
MASIMO ALERT: Bragar Eagel & Squire, P.C. is Investigating Masimo Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
March 21, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Masimo Named One of Fast Company’s Most Innovative Companies in North America
March 19, 2024
From
Masimo
Via
Business Wire
Apple Watch 2.0? New Patents Hint At Expansion Beyond Health Tracking After Masimo Fiasco
March 15, 2024
Apple has been considering incorporating anemometers, bolometers, heat flux sensors, solar radiation sensors, thermometers, and water sensors into future iterations of the Apple Watch.
Via
Benzinga
Topics
Intellectual Property
Exposures
Intellectual Property
Masimo Celebrates Multiple Wins at the iF DESIGN AWARDS 2024
March 07, 2024
From
Masimo
Via
Business Wire
Masimo to Present in 45th Annual Raymond James Institutional Investors Conference
March 04, 2024
From
Masimo Corporation
Via
Business Wire
Masimo Reports Fourth Quarter and Full-Year 2023 Financial Results
February 27, 2024
From
Masimo Corporation
Via
Business Wire
Masimo and UCHealth Announce a Clinical Monitoring Partnership to Improve Care with Telehealth
February 20, 2024
From
Masimo
Via
Business Wire
Masimo Announces the First FDA-cleared “Over-the-Counter” Fingertip Pulse Oximeter
February 13, 2024
From
Masimo
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
18
19
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.